The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study, PLoS Negl Trop Dis, vol.4, 2010. ,
Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis, Nat Microbiol, vol.1, p.15008, 2016. ,
Melioidosis is in the Americas: a call to action for diagnosing and treating the disease, Am J Trop Med Hyg, vol.99, pp.563-567, 2018. ,
Melioidosis in Mexico, Central America, and the Caribbean, Trop Med Infect Dis, vol.3, p.24, 2018. ,
A review of melioidosis cases in the Americas, Am J Trop Med Hyg, vol.93, pp.1134-1143, 2015. ,
Identification and discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by real-time PCR targeting type III secretion system genes, J Clin Microbiol, vol.42, pp.5871-5875, 2004. ,
Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei, J Clin Microbiol, vol.43, pp.479-83, 2005. ,
Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei, J Clin Microbiol, vol.41, pp.2068-79, 2003. ,
Burkholderia pseudomallei, the causative agent of melioidosis, is rare but ecologically established and widely dispersed in the environment in Puerto Rico, PLoS Negl Trop Dis, vol.13, 2019. ,
Diabetes mellitus and obesity in the French Caribbean: a special vulnerability for women? Women Health, vol.58, pp.145-59, 2018. ,